section name header

Table 48.4

Management of Oral Therapy for Acute Heart Failure in the First 48h

HypotensionLow heart ratePotassiumRenal impairment
Normotension/Hypertension85–100 mmHg<85 mmHg<60 50/min<50/min3.5 mg/dl>5.5 mg/dlCr <2.5, eGFR >30Cr >2.5, eGFR <30
ACE-I/ARBReview/IncreaseReduce/StopStopNo changeNo changeReview/IncreaseStopReviewStop
Beta blockerNo changeReduce/StopStopReduceStopNo changeNo changeNo changeNo change
MRANo changeNo changeStopNo changeNo changeReview/IncreaseStopReduceStop
DiureticsIncreaseReduceStopNo changeNo changeReview/No changeReview/IncreaseNo changeReview
Other vasodilarors (nitrates)IncreaseReduce/StopStopNo changeNo changeNo changeNo changeNo changeNo change
Other heart rate slowing drugs (amiodarone, CCB, Ivabradine)ReviewReduce/StopStopReduce/StopStopReview/Stop (*)No changeNo changeNo change

Legends: CCB, calcium channel blockers; Cr, creatinine blood level (mg/dl); eGFR, estimated glomerular filtration rate mL/min/1.73 m2; MRA, mineralocorticoid receptor antagonist; (*) amiodarone.

Source: Mebazaa A, Yilmaz MB, Levy P, et al. (2015) Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine. European Journal of Heart Failure 17, 544–558. Reproduced with permission of John Wiley & Sons.